Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to measure the safety (side effects) of an Omega 3
Fatty acid called docosahexanoic acid (DHA) and measure the dyskinesia (involuntary
movements) in Parkinson 's disease (PD).